RNA vaccine

Sanofi is dropping plans to develop its mRNA Covid-19 vaccine despite positive results in phases 1 and 2 because of Pfizer/BioNTech and Moderna's dominance in the market, the French pharma corporation announced on Tuesday.

Özlem Türeci and Uğur Şahin, the co-founders of BioNTech, and Katalin Kario, who also works at the Germany-based, biotechnology firm has been announced as the recipients of Germany's most prestigious medicine prize for their mRNA vaccine work.

They will receive the Paul Ehrlich and Ludwig Darmstaedter Prize 2022 on March 14.

Katalin Kariko, the Hungarian-born scientist who laid the groundwork for the mRNA vaccines fighting COVID-19, has been recognized in her homeland in the form of a huge mural in central Budapest.

class='cf'>

The efficacy of anti-COVID-19 vaccines of Pfizer and Moderna companies has decreased from 91 to 66 percent since the Delta variant of the novel coronavirus that causes this infectious disease has become dominant in the United States. This brcame clear from data published by a Federal health agency, Frrance Press reported.

The World Health Organization said on July 9 that there was a "likely causal association" between coronavirus vaccines using mRNA technology and "very rare" heart inflammations, but the benefits still outweigh the risks.

According to a new study, nearly all patients with cancer developed a good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose.

İYİ (Good) Party leader Meral Akşener has said they would move a motion in parliament to nominate the Turkish-origin co-founders of German biotechnology company BioNTech for the Nobel prize for leading vaccine development against COVID-19.

A top official in the European Medicines Agency said it might be worth abandoning AstraZeneca's coronavirus vaccine for all age groups where alternatives are available, in an interview published on June 13.

Marco Cavaleri, the EMA's head of vaccine strategy, also told Italy's La Stampa newspaper that the Johnson & Johnson jab should be preferentially used for the over 60s.

By George Gilson

The global terror wrought by COVID-19 is perhaps most intensely felt by immunosuppressed patients who amidst the wholly justified international jubilation over the discovery of vaccines suddenly discover they are not among the lucky ones.

The emotional roller coaster ride is jolting as I discovered after the second jab of the Pfizer mRNA vaccine.

But, even after revaccination, you are not completely protected, American experts warn.